Areas of Research
Principal Investigators in this Research Area:
A long-term objective of Dr. Silberstein’s research laboratory is to better define niche-induced signals and… More
Center for Human Cell Therapy
The Center for Human Cell Therapy (CHCT) at the PCMM was established to provide an infrastructure to rapidly translate novel cell therapy protocols from the laboratory to the clinic. The Center is a cross-institutional effort, drawing its leadership and resources from the following institutions: Boston Children’s Hospital (BCH), Dana-Farber Cancer Institute (DFCI), and Massachusetts General Hospital (MGH). Anchored by its Translational Cell Therapy Laboratory (TransLab) and its Regulatory Core, the Center is designed to provide cell therapy resources for the Harvard community and its affiliated hospitals, from the technical level to the submission of Clinical Protocols and Investigational New Drug applications.
The mandate of the CHCT is to provide resources to all Harvard Medical School faculty to facilitate bench-to-bedside development of cellular therapies for the treatment of damaged or diseased tissues. Examples of such diseases include the correction of congenital defects and various cancers such as childhood and adult leukemia, prostate and ovarian cancers.
Related News and Announcements
Center for Human Cell Therapy Boston Awarded 5 year Production Assistance for Cellular Therapy (PACT) contract by the National Heart, Lung and Blood Institute to advance cell therapy research
On January 15th 2010, Dr. Leslie E. Silberstein of the Center for Human Cell Therapy Boston (CHCT) at the Immune Disease Institute was awarded a Production Assistance for Cellular Therapies contract (PACT) by the National Institutes of… Read Full Article »